Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-22T22:38:25.807Z Has data issue: false hasContentIssue false
  • English
  • Français

Healthcare Costs Associated with Hemodialysis Catheter–Related Infections: A Single-Center Experience

Published online by Cambridge University Press:  02 January 2015

Venkataraman Ramanathan ,
Edwin J. Chiu ,
Jim T. Thomas ,
Ahmad Khan ,
George M. Dolson  and
Rabih O. Darouiche
Venkataraman Ramanathan*
Affiliation:
Renal Section, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
Edwin J. Chiu
Affiliation:
Renal Section, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
Jim T. Thomas
Affiliation:
Renal Section, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
Ahmad Khan
Affiliation:
Renal Section, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
George M. Dolson
Affiliation:
Renal Section, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
Rabih O. Darouiche
Affiliation:
Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas Center for Prostheses Infection, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
*
Renal Section, MED VA Medical Center, 2002 Holcombe Blvd., 111-J, Houston, TX 77030 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

In patients undergoing hemodialysis, catheter-related bacteremia results in expensive hospitalizations. In our study, the mean cost was $23,451 per hospitalization. When itemized, housing (“bed-related”) costs accounted for 66% of the total; laboratory costs accounted for 4%, radiologic costs accounted for 9%, and procedure-related costs accounted for 21%. Hypoalbuminemia and bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA) are associated with higher healthcare costs; bacteremia due to MRSA is also associated with poor survival rates.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 5 , May 2007 , pp. 606 - 609
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. US Department of Health and Human Services, Centers for Medicare and Medicaid Services. CMS launches "fistula first" initiative to improve care and quality of life for hemodialysis patients. Available at: http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1007. Accessed July 4, 2006.Google Scholar
2. Pisoni, RL, Young, EW, Dykstra, DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002;61:305–316.Google Scholar
3. Nori, US, Manoharan, A, Thornby, JI, Yee, J, Parasuraman, R, Ramanathan, V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant 2006;21:2184–2190.Google Scholar
4. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2005 Annual Data Report. Bethesda, MD. Available at: http://www.usrds.org/adr.htm. Accessed July 4, 2006.Google Scholar
5. Nissenson, AR, Dylan, ML, Griffiths, RI, et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 2005;46:301–308.Google Scholar
6. Reed, SD, Friedman, JY, Engemann, JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:175–183.Google Scholar
7. Engemann, JJ, Carmeli, Y, Cosgrove, SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592–598.Google Scholar
8. Engemann, JJ, Friedman, JY, Reed, SD, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005;26:534–539.Google Scholar
9. Department of Health and Human Services. Centers for Disease Control and Prevention. 12 steps to prevent antimicrobial resistance among dialysis patients. Available at: http://www.cdc.gov/drugresistance/healthcare/dialysis/12steps_dialysis.htm. Accessed August 2, 2006.Google Scholar
10. Unver, S, Atasoyu, EM, Evrenkaya, TR, Ardic, N, Ozyurt, M. Risk factors for the infections caused by temporary double-lumen hemodialysis catheters. Arch Med Res 2006;37:348–352.Google Scholar
11. Cooper, BA, Penne, EL, Bartlett, LH, Pollock, CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004;43:61–66.Google Scholar
12. Kalantar-Zadeh, K, Kilpatrick, RD, Kuwae, N, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005;20:1880–1888.Google Scholar
13. Ramanathan, V, Parasuraman, R, Manoharan, A, Nori, US. Epidemiologic trend of infective endocarditis in hemodialysis patients. J Am Soc Nephrol 2004;15:402A.Google Scholar
14. Kopp, BJ, Nix, DE, Armstrong, EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004;38:1377–1382.CrossRefGoogle ScholarPubMed
15. Cosgrove, SE, Qi, Y, Kaye, KS, Harbarth, S, Karchmer, AW, Carmeli, Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166–174.Google Scholar